About Leslie Kreis, Jr.
Leslie Kreis, Jr. is a director and 10% owner at Actuate Therapeutics.
Leslie Kreis, Jr. reports to the SEC as a director or major shareholder of 5 public companies, including Cognition Therapeutics (CGTX), Lantern Pharma (LTRN) and IN8BIO (INAB).
Leslie Kreis, Jr. first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Leslie Kreis, Jr. in the role, so the role may have started earlier or lasted longer.
CI
Cognition Therapeutics Inc.
Director and 10% owner
2022 – 2025 · Public company (CGTX)
LI
Lantern Pharma Inc.
Director and 10% owner
2020 – 2025 · Public company (LTRN)
II
IN8BIO, Inc.
Director and 10% owner
2021 – 2025 · Public company (INAB)
AI
Azitra, Inc.
10% owner
2023 · Public company (AZTR)
Key Colleagues at Startups
The people Leslie Kreis, Jr. works with at each company, as listed on that company's latest Form D.
Actuate Therapeutics, Inc. · Form D, Mar 6, 2024
AF
Aaron Fletcher
Director
DS
Daniel Schmitt
President and Chief Executive Officer, director
DZ
Dan Zabrowski
Director
TT
Todd Thomson
Director